Cormorant Asset Management, LP Q4 2016 Filing
Filed February 14, 2017
Portfolio Value
$741.8B
Holdings
77
Report Date
Q4 2016
Filing Type
13F-HR
All Holdings (77 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | —PROTEOSTASIS THERAPEUTICS IN | 3,804,027 | $46.6B | 6.29% | |
| 2 | TBPHTHERAVANCE BIOPHARMA INC | 1,425,000 | $45.4B | 6.12% | |
| 3 | NVROEURNEVRO CORP | 601,044 | $43.7B | 5.89% | |
| 4 | —ALDER BIOPHARMACEUTICALS INC | 1,581,604 | $32.9B | 4.43% | |
| 5 | EGRXEAGLE PHARMACEUTICALS INC | 410,000 | $32.5B | 4.38% | |
| 6 | NERVGBPMINERVA NEUROSCIENCES INC | 2,652,436 | $31.2B | 4.20% | |
| 7 | ARDXARDELYX INC | 2,071,964 | $29.4B | 3.97% | |
| 8 | ACRSACLARIS THERAPEUTICS INC | 976,286 | $26.5B | 3.57% | |
| 9 | HRTXHERON THERAPEUTICS INC | 1,951,263 | $25.6B | 3.45% | |
| 10 | 2L9BLUEPRINT MEDICINES CORP | 841,752 | $23.6B | 3.18% | |
| 11 | GLPGGALAPAGOS NV | 334,044 | $21.4B | 2.89% | |
| 12 | CRBPEURCORBUS PHARMACEUTICALS HLDGS | 2,500,000 | $21.1B | 2.85% | |
| 13 | CLSDUSDCLEARSIDE BIOMEDICAL INC | 2,333,333 | $20.9B | 2.81% | |
| 14 | —MYOKARDIA INC | 1,445,090 | $18.7B | 2.52% | |
| 15 | PTGXPROTAGONIST THERAPEUTICS INC | 720,000 | $15.8B | 2.13% | |
| 16 | CHRSCOHERUS BIOSCIENCES INC | 519,090 | $14.6B | 1.97% | |
| 17 | —QUOTIENT LTD | 2,940,000 | $14.2B | 1.92% | |
| 18 | NBIXNEUROCRINE BIOSCIENCES INC | 359,000 | $13.9B | 1.87% | |
| 19 | WVEWAVE LIFE SCIENCES LTD | 507,907 | $13.3B | 1.79% | |
| 20 | —CHINA BIOLOGIC PRODS INC | 112,867 | $12.1B | 1.64% | |
| 21 | —PORTOLA PHARMACEUTICALS INC | 537,000 | $12.1B | 1.62% | |
| 22 | —INC RESH HLDGS INC | 200,000 | $10.5B | 1.42% | |
| 23 | ARRYEURARRAY BIOPHARMA INC | 1,150,000 | $10.1B | 1.36% | |
| 24 | FLGTFULGENT GENETICS INC | 857,663 | $9.9B | 1.34% | |
| 25 | OMEROMEROS CORP | 975,000 | $9.7B | 1.30% | |
| 26 | SRNESORRENTO THERAPEUTICS INC | 1,909,000 | $9.4B | 1.26% | |
| 27 | —SYNERGY PHARMACEUTICALS DEL | 1,500,000 | $9.1B | 1.23% | |
| 28 | —AUDENTES THERAPEUTICS INC | 449,660 | $8.2B | 1.11% | |
| 29 | RAREULTRAGENYX PHARMACEUTICAL IN | 110,842 | $7.8B | 1.05% | |
| 30 | —ZYNERBA PHARMACEUTICALS INC | 480,501 | $7.5B | 1.01% | |
| 31 | —CURIS INC | 2,410,900 | $7.4B | 1.00% | |
| 32 | COLLCOLLEGIUM PHARMACEUTICAL INC | 455,515 | $7.1B | 0.96% | |
| 33 | —GEMPHIRE THERAPEUTICS INC | 900,000 | $7.1B | 0.95% | |
| 34 | RIGLUSDRIGEL PHARMACEUTICALS INC | 2,868,700 | $6.8B | 0.92% | |
| 35 | —CONTRAFECT CORP | 3,842,966 | $6.7B | 0.91% | |
| 36 | AGENEURAGENUS INC | 1,421,000 | $5.9B | 0.79% | |
| 37 | —PFENEX INC | 632,559 | $5.7B | 0.77% | |
| 38 | CNCEEURCONCERT PHARMACEUTICALS INC | 538,422 | $5.5B | 0.75% | |
| 39 | DC4DEXCOM INC | 90,000 | $5.4B | 0.72% | |
| 40 | —DERMIRA INC | 172,083 | $5.2B | 0.70% | |
| 41 | —FORWARD PHARMA A/S | 339,175 | $5.1B | 0.69% | |
| 42 | SCTLRECRO PHARMA INC | 603,000 | $4.9B | 0.66% | |
| 43 | —INTEC PHARMA LTD JERUSALEM | 809,804 | $4.6B | 0.62% | |
| 44 | —INVUITY INC | 767,466 | $4.4B | 0.59% | |
| 45 | CTMXCYTOMX THERAPEUTICS INC | 371,636 | $4.1B | 0.55% | |
| 46 | —SUNESIS PHARMACEUTICALS INC | 1,000,000 | $3.6B | 0.49% | |
| 47 | —ADVANCED ACCELERATOR APPLIC | 124,220 | $3.3B | 0.45% | |
| 48 | ASNDASCENDIS PHARMA A S | 162,254 | $3.3B | 0.44% | |
| 49 | XLRNACCELERON PHARMA INC | 127,451 | $3.3B | 0.44% | |
| 50 | —AGILE THERAPEUTICS INC | 563,880 | $3.2B | 0.43% | |
| 51 | RGNXREGENXBIO INC | 156,741 | $2.9B | 0.39% | |
| 52 | —CATABASIS PHARMACEUTICALS IN | 800,000 | $2.9B | 0.39% | |
| 53 | CRVSCORVUS PHARMACEUTICALS INC | 198,526 | $2.8B | 0.38% | |
| 54 | —LIPOCINE INC NEW | 751,296 | $2.8B | 0.37% | |
| 55 | XNCRXENCOR INC | 100,000 | $2.6B | 0.35% | |
| 56 | —ONCOBIOLOGICS INC | 833,333 | $2.5B | 0.34% | |
| 57 | —AQUINOX PHARMACEUTICALS INC | 151,838 | $2.5B | 0.34% | |
| 58 | —ABEONA THERAPEUTICS INC | 500,000 | $2.4B | 0.33% | |
| 59 | —AVEXIS INC | 49,991 | $2.4B | 0.32% | |
| 60 | —IMMUNE DESIGN CORP | 432,990 | $2.4B | 0.32% | |
| 61 | GBYSANGAMO BIOSCIENCES INC | 650,000 | $2.0B | 0.27% | |
| 62 | —EPIZYME INC | 159,513 | $1.9B | 0.26% | |
| 63 | —TIGENIX | 129,032 | $1.9B | 0.25% | |
| 64 | GLYCEURGLYCOMIMETICS INC | 287,031 | $1.8B | 0.24% | |
| 65 | SNDXSYNDAX PHARMACEUTICALS INC | 240,403 | $1.7B | 0.23% | |
| 66 | —APTOSE BIOSCIENCES INC | 990,579 | $1.4B | 0.19% | |
| 67 | —MYOVANT SCIENCES LTD | 100,000 | $1.2B | 0.17% | |
| 68 | NSTGEURNANOSTRING TECHNOLOGIES INC | 40,490 | $903.0M | 0.12% | |
| 69 | —AVEO PHARMACEUTICALS INC | 1,087,715 | $587.0M | 0.08% | |
| 70 | —HTG MOLECULAR DIAGNOSTICS IN | 203,464 | $456.0M | 0.06% | |
| 71 | —THRESHOLD PHARMACEUTICAL INC | 1,012,255 | $446.0M | 0.06% | |
| 72 | —ONCOBIOLOGICS INC - CW17 -B | 416,666 | $329.0M | 0.04% | |
| 73 | —NEOS THERAPEUTICS INC | 50,613 | $296.0M | 0.04% | |
| 74 | —APPLIED GENETIC TECHNOLOGIES | 17,321 | $162.0M | 0.02% | |
| 75 | —ONCOBIOLOGICS INC | 416,666 | $79.0M | 0.01% | |
| 76 | —CELLECTAR BIOSCIENCES INC | 53,649 | $65.0M | 0.01% | |
| 77 | —CELLECTAR BIOSCIENCES INC | 52,999 | $10.0M | 0.00% |